by Physicist Gary Wade (11/17/07)



L-tryptophan is an essential amino acid.  It is also a precursor for serotonin biosynthesis.  Serotonin is a neurotransmitter essential for proper brain function.  Before its withdrawal from the market in 1989 by the FDA, L-tryptophan had been used extensively for 15 years as a safe, non-addictive, effective, and cheap, mood enhancer, memory aid, relaxer and sleep aid.(21,22,23,24,25,26,27)   However, in 1989 a mysterious new syndrome Eosinophilia-Myalgia Syndrome (EMS) was discovered and associated with the taking of L-tryptophan.(28)   Several dozens of people died and several thousand people suffered debilitating illness.  The source cause of EMS was eventually traced to impurities in the L-tryptophan sold by the Japanese pharmaceutical company of Showa Denko K.K., Tokyo, Japan.(29)   Showa Denko made several manufacturing procedural changes in L-tryptophan manufacturing between December 1988 and June 1989.  These changes had the net effect of essentially lowering purification standards in their new genetically engineered L-tryptophan manufacturing process.(30,31,32,33,34,35)   It should also be noted that the FDA went to some trouble to conceal the fact that the L-tryptophan in question was produced through genetic engineering.(36)  


Even though L-tryptophan was proven not to be the cause of EMS and the L-tryptophan from all other manufacturers on the planet was shown to be safe, the FDA has refused to allow L-tryptophan supplements to once again be sold in health food stores or over the counter in drug stores.  However, the FDA does still allow the use of many prescription drugs as sleep aids which have serious side effects ( toxic / dangerous ) and which make pharmaceutical companies and their AMA drug pushers huge profits.  The sleeping pill drug Halcyon, which was reportedly used regularly by both former Secretary of State James Baker the 3rd and former president George Bush has very dangerous side effects, which you can read about in the Physicians Desk Reference.  As an example of a Halcyon side effect, remember when former president Bush (senior) vomited at a  Japanese  State Dinner ?  


There are no legitimate reasons for the FDA keeping L-tryptophan supplements off the market.  The FDA keeping L-tryptophan off the market is like keeping aspirin or penicillin off the market because one manufacture somewhere in the world once made a series of contaminated batches of the  product.  The situation we have here is corrupt administrators and lawyers in the FDA using the FDA's unchecked legal powers, in the guise of public safety, to remove from the market place a safe, effective, and cheap competitor compound to the dangerous and expensive prescription drugs supplied by the pharmaceutical companies and pushed by the AMA drug pushers, who cannot seem to remember their Hippocratic oath  (..."do no harm"...). 


The former commissioner of the FDA, David Kessler is both an M.D. and an attorney, he understands completely how he and his AMA brethren have continually violated their Hippocratic oath and how he has betrayed the public trust not only in the L-tryptophan matter, but in a large number of other duplicitous actions.  The FDA under commissioner Kessler  planned to adopt regulations, which will put all health food store supplements and products under their control, so as to remove from public access all effective, safe, and cheap products which compete with generally toxic pharmaceutical company products.  After Kessler’s forced resignation as FDA Commissioner for his blatant fraud filings in his trip expense reports, his successors have continued to find ways to suppress the availability of effective, safe and cheap nutritional products which compete with generally toxic pharmaceutical products.  They have now succeeded using Codex Alimentarius, which the FDA signed off on the 4th  of July 2006.  Under the Codex Alimentarius agreement which is under a treaty agreement which has authority over U.S. Federal law, all vitamin, mineral, and nutritional supplement availability and available dose amount must be made the same as those allowed in the European Union (EU).  Currently in the EU all over- the-counter vitamin and mineral supplement dose levels have been reduced to ridiculous low amounts, e.g., vitamin C in 10 mg doses.  The FDA has not attempted to implement Codex Alimentarius yet, but they will and we should use this as a catalyst to take the FDA apart.  The cumulative results of the FDA/pharmaceutical cartel plan is tantamount to committing mass manslaughter on the American public, while the AMA members, the pharmaceutical companies, and insurance companies reap huge profits from the associated unnecessary illnesses, disease,  prematurely aging and dying of the general public.   It may seem strange at first that insurance companies will make more money from more illness, but if you take a close look at how insurance companies actually work, it will become clear how illness equates to profit.  Currently 2/3 of the HMOs are owned by insurance companies.  This should never have been allowed to happen.  However, we do live and die under a corporate controlled U.S. government; greed rules.  Have you noticed that approximately half of “your” lawmakers in Washington, D.C. were corporate attorneys before they came to D.C.?


An excellent example of the rampant ethical and moral corruption which exists and is running rampant inside the FDA and other governmental public health organizations is provided by an article in The Journal Of Clinical Investigation of March 1993, Volume 91, p. 804-811.  In this article scientists at the Center for Food Safety and Applied Nutrition at the FDA, ran experiments using the Lewis rat.  They feed the rats contaminated L-tryptophan, with similar contaminants to the Showa Denko K.K. bad L-tryptophan batches, and pure L-tryptophan.  The researchers falsely claimed that the rat dosage (2,000 mg / kg of body weight per day) of L-tryptophan represented or corresponded to a human dosage of 5 to 6 grams a day.  However, a dosage of 2,000 gm / kg of body weight per day corresponds to:


( 2,000 mg / kg of body wt. / day)  ( 70 kg / person )  =  140 grams / day / person.  This is an "error" of well more than a factor of twenty.  Yet, only the contaminated L-tryptophan resulted in the characteristic symptoms of EMS.  The pure L-tryptophan dosage resulted in only minor pathology.  The authors of this disgraceful article wrongly claimed the minor pathology resulting from the massive dosage of pure L-tryptophan proved pure L-tryptophan was a contributing factor to the development of EMS.  This study was apparently carried out to give the corrupt FDA administrators and their corrupt legal department something to use in the guise of public safety concerns for justification of the continued removal from the over-the-counter market of a safe, effective, and cheap competitor of the highly profitable and toxic prescription drugs produced by pharmaceutical companies and pushed by AMA doctors.  How would you like these same researchers to conduct tests on all of your favorite over the counter drug products and food supplements?  For example:


Question-  What do you think would happen to you if you took 140 grams of aspirin a day?

Answer-  You would die on the first or second day from massive hemorrhages.

The most disturbing thing about this disgraceful article is that this article included as authors thirteen scientists from not only the FDA, but the National Institutes of Health, National Institutes of Mental Health, National Institutes of Cancer, and other Institutes.  Do you want these scientists ostensibly looking out for your health and well being?  Sorry, that is what they are doing right now.


What “We the People” need is a greatly reformed AMA and FDA.  This will require a grass roots movement that will go actively after the corruption in the leadership in both the AMA and FDA, that was facilitated/generated by and maintained by, the greed and corruption of the multinational drug cartel.



·        This article was extracted from Appendix H of the paper:  Dr. Rife and the Death of the Cancer Industry.




21)     S.E. Moller, C. Kirk, P. Honore, J. Affective Disord. 1980; 2:47 – 59.

22)     G.F. Wilcock, J. Stevens, A. Perkins, Lancet 1987; 1: 929 – 930; J. Volanka, M. Crowner, D. Brozer, et al. Biol. Psychiatry 1990; 28: 728 -732.

23)     N. Hrboticky, G.H. Anderson, Nutr. Res. 1985; 5:595 – 607.

24)     A.F. Sued, C.M. Van Itallie, J.D. Fernstrom, J. Pharmacol. Esp. Ther. 1982; 221:329 – 332.

25)     G.E. Pakes, Drug Intell. Clin. Pharm. 1979; 13:391 – 396.

26)     R.E. McGrath, B. Buckwald, E.V. Resmick, J. Clin. Psychiatry 1990; 51: 162 – 163.

27)     E. Hartman, C.L. Spinweber, J. Nerv. Ment. Dis. 1979; 167: 447 – 449; E. Hartman, Psychiatric Res. 1983; 17: 107 – 113; D. Schneider-Helmet, C.L. Spinweber, Psychopharmacology 1986; 89: 1 – 7.

28)     P.A. Hertzman, W.C. Blevins, J. Mayer, et al., N. Engl. J. Med. 1990; 322: 869 – 874.

29)     L. Slusker, F.C. Hoesly, L. Miller, et al., JAMA 1990; 264: 213 – 217.

30)     E.A. Belongia, V.W. Hedberg, G.J. Gleich, et al., N. Engl. J. Med. 1990; 323: 357 – 366.

31)     L.D. Kaufman, R.M. Philen, Drug Safety 1993; 8: 89 – 98.

32)     T. Toyooka, T. Yamazaki, T. Tanimato, et al., Chem. Pharm. Bull. 1991; 39: 820 – 822.

33)     Centers for Disease Control, MMWR 1990; 39: 589 – 591.

34)     A.N. Mayeno, F. Lin, C.S. Foote, et al., Science 1990; 250: 1707 – 1708.

35)     Centers for Disease Control, MMWR 1990; 39: 789 – 790.

36)     L. Roberts, Science 1990; 249: 988.